Web4-Hydroxycyclophosphamide is in the class of oxazaphosphorine compounds, and is the main, active metabolite of cyclophosphamide and of mafosfamide after they partially metabolized by cytochrome P450. It is then partially tautomerized into aldophosphamide, which, in turn, easily enters live cells and then is partially detoxified into inactive ... WebFeb 1, 2007 · In der Cyclophosphamid-Gruppe wurden mehr Infekte registriert (Unterschied nicht signifikant). In 23% trat eine Amenorrhö im Vergleich zu 0% in der …
Prospektive Verlaufsbeobachtung einer universitären ...
WebSep 10, 2015 · Forty patients (56%) received second-line therapy ().Median time to next treatment was 51 months. Among patients who received second-line treatment, 28 (70%) were retreated with a rituximab-based regimen with high response rates (82% achieved at least a minor response); 12 patients (30%) were treated with alkylating agents, … WebBook. Editors: Fink, Gereon R.; Gold, Ralf; Berlit, Peter Authors: Arendt, Gabriele; Aschenberg, Sophie; Ayzenberg, Ilya; Baldermann, Juan; Barbe, Michael; Becker ... theoretical framework of mobile gaming
Cyclophosphamide - PubMed
WebTrade Name: SYKLOFOSFAMID, CYCLOBLASTIN, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMID, CYCLOSTIN, NEOSAR Chemical Family: Alkylating Agent Intended Use: Pharmaceutical product used as Antineoplastic 2. HAZARDS IDENTIFICATION Appearance: White crystalline powder Signal Word: DANGER Statement of Hazard: … WebCyclophosphamide is approved to be used alone or with other drugs to treat: Acute lymphoblastic leukemia (ALL) in children. Acute monocytic leukemia. Acute myeloid … WebCyclophosphamide is type of drug known as a disease-modifying anti-rheumatic drug (DMARD). When people have an autoimmune condition, the body’s immune system can mistakenly cause harm to healthy tissues. Cyclophosphamide can stop this happening by reducing the effects of the overactive immune system. It can be prescribed for more … theoretical framework of online banking